Reversible left bundle branch block should be mentioned in cardiac resynchronization therapy; A clinical case report

Vasheghani-Farahani, Ali; Tajdini, Masih; Mohsenizadeh, Seyed Abolfazl; Hosseini, Seyed Mohammad Reza

Reversible left bundle branch block should be mentioned in cardiac resynchronization therapy; A clinical case report

Document Type : Case Report

Authors

Ali Vasheghani-Farahani ¹

Masih Tajdini ²

Seyed Abolfazl Mohsenizadeh ²

Seyed Mohammad Reza Hosseini ³

¹ Associate Professor, Tehran Heart Center AND Department of Cardiology, Tehran University of Medical Sciences, Tehran, Iran

² Resident, Tehran Heart Center AND Department of Cardiology, Tehran University of Medical Sciences, Tehran, Iran

³ General Practitioner, Department of Radiology, Massachusetts General Hospital, Boston, MI

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) is a medical device to help cardiac synchronized contractility by electrical impulses. Improvement of symptoms and left ventricular systolic function, reducing hospital admissions and mortality in patients with moderate to severe heart failure are the main benefits of administration of cardiac resynchronization therapy. CASE REPORT: In this article, we describe a case of heart failure and left bundle branch block (LBBB) who was candidate for cardiac resynchronization therapy; but after managing hyperkalemia, left bundle branch block resolved, ejection fraction increased and cardiac resynchronization therapy implantation was canceled. CONCLUSION: Exclusion of treatable causes is the first important step before any interventions. Now there is an important question; is cardiac resynchronization therapy effective in patients with heart failure and transient or intermittent left bundle branch block?

Keywords

Reversible Left Bundle Branch Block

Cardiac Resynchronization Therapy

Hyperkalemia

Willis HJ. Left bundle-branch block-pathophysiology, prognosis, and clinical management. Clin Cardiol 2007; 30(10): 535.
Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NA 3rd, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 60(14): 1297-313.
St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107(15): 1985-90.
Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med 2004; 27(2): 153-60.
Wilmot E, Sagili V, Sturrock N. An rare cause of reversible left bundle branch block. Endocrine Abstracts 2007; 13: 23.
Fisher JD, Aronson RS. Rate-dependent bundle branch block: occurrence, causes and clinical correlations. J Am Coll Cardiol 1990; 16(1): 240-3.
Parenti N, Binetti N, Lenzi T. "Reversible" left bundle branch block in acute carbon monoxide poisoning. Intern Emerg Med 2006; 1(2): 172-3.
Alhaji M. Intermittent left bundle branch block caused by coronary vasospasm. Avicenna J Med 2013; 3(2): 50-2.
Juraschek SP, Kovell LC, Childers RE, Chow GV, Hirsch GA. Heart failure with transient left bundle branch block in the setting of left coronary fistula. Cardiol Res Pract 2011; 2011: 786287.